It will therefore be of particular interest to further study these transcription factors in pathological situations inducing muscle wasting, and also to evaluate their impact on muscle tissue in metabolic diseases where abnormalities in SREBP-1 have already been reported, such as insulin-resistance and type 2 diabetes [5], [41], [42]. The gene discussed is SREBF1; the disease is Insulin resistance.